Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jul 21;46(28):2780-2791.
doi: 10.1093/eurheartj/ehaf248.

Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation study

Affiliations
Multicenter Study

Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation study

Aaron Long et al. Eur Heart J. .

Abstract

Background and aims: Classification and risk stratification in aortic (AR), mitral (MR), and tricuspid regurgitation (TR) remains a significant clinical challenge. This study aimed to develop an artificial intelligence (AI) system to assess valvular regurgitation and stratify MR-progression risk.

Methods: Using transthoracic echocardiograms (TTEs) at two sites (internal development/test, external test), the DELINEATE-Regurgitation system was developed to classify AR, MR, and TR severity using colour Doppler videos. Methods of summating video-level classifications into study-level predictions were tested, comparing single-view with multiview approaches integrating predictions across multiple videos. Model agreement with cardiologists was assessed by weighted kappa. A separate AI system (DELINEATE-MR-Progression) analysing colour Doppler videos was developed to predict which patients with mild, mild-moderate, and moderate MR were most likely to progress to moderate-severe or severe MR with analysis by Kaplan-Meier and Cox proportional hazards models.

Results: A total of 71 660 TTEs with 1 203 980 colour Doppler videos were included. The weighted kappa in internal/external test sets for regurgitation classification was 0.81/0.76 for AR, 0.76/0.72 for MR, and 0.73/0.64 for TR using a multiview approach taking all colour Doppler videos in a study, demonstrating substantial agreement with cardiologist interpretation with superiority of multiview over single view approaches. In the progression analysis, the AI score stratified MR-progression risk even when controlled for clinical factors known to be associated with MR progression [internal test set hazard ratio 4.1 (95% confidence interval 2.5-6.6)].

Conclusions: An AI system can accurately classify AR, MR, and TR and predict MR progression beyond currently known risk factors.

Keywords: Aortic regurgitation; Artificial intelligence; Deep learning; Echocardiography; Mitral regurgitation; Tricuspid regurgitation.

PubMed Disclaimer

Figures

Structured Graphical Abstract
Structured Graphical Abstract
Figure 1
Figure 1
Patient Flow for Regurgitation Classification Cohort (Panel A) and Mitral Regurgitation Progression Cohort (Panel B). These figures demonstrate patient flow for the AR, MR, and TR classification study (Panel A) and the MR progression study (Panel B)
Figure 2
Figure 2
Model Performance by Confusion Matrices for Multiview All Model for the 4-Grade Classification of Aortic Regurgitation (Panel A and B), Mitral Regurgitation (Panel C and D), and Tricuspid Regurgitation (Panel E and F). These figures demonstrate the agreement of the AI valvular regurgitation classification system to cardiologist assessment in the internal and external test sets for AR, MR, and TR
Figure 3
Figure 3
Kaplan–Meier Analysis of using the DELINEATE-MR-Progression Deep Learning Model to Discriminate Risk of MR Progression in the Internal Test Set (panel A) and External Test Sets (panel B). These figures demonstrate the use of the DELINEATE-MR-Progression model to predict the risk of progression in patients with mild, mild–moderate, and moderate MR. The AI risk was stratified by tertiles of risk for each grade of MR and accurately stratified risk of progression to moderate–severe or severe MR by 2 years

References

    1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561–632. 10.1093/eurheartj/ehab395 - DOI - PubMed
    1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2021;143:e72–227. 10.1161/CIR.0000000000000923 - DOI - PubMed
    1. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30:303–71. 10.1016/j.echo.2017.01.007 - DOI - PubMed
    1. Coisne A, Aghezzaf S, Edmé JL, Bernard A, Ma I, Bohbot Y, et al. Reproducibility of reading echocardiographic parameters to assess severity of mitral regurgitation. Insights from a French multicentre study. Arch Cardiovasc Dis 2020;113:599–606. 10.1016/j.acvd.2020.02.004 - DOI - PubMed
    1. Biner S, Rafique A, Rafii F, Tolstrup K, Noorani O, Shiota T, et al. Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity. JACC Cardiovasc Imaging 2010;3:235–43. 10.1016/j.jcmg.2009.09.029 - DOI - PubMed

Publication types